Oxycontin and Viracept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxycontin (oxycodone hydrochloride) and Viracept (nelfinavir mesylate). Common drug interactions include skin disorder among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Oxycontin and Viracept. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Oxycontin?

Oxycontin has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 212,533 Oxycontin users. Check the latest studies of Oxycontin.

What is Viracept?

Viracept has active ingredients of nelfinavir mesylate. It is often used in hiv infection. eHealthMe is studying from 6,399 Viracept users. Check the latest studies of Viracept.



On Jul, 13, 2026

35 people who take Oxycontin and Viracept together, and have interactions are studied.

Oxycontin and Viracept drug interactions.

What are the common drug interactions of Oxycontin and Viracept, by gender? *:

female:

  1. Skin disorder (skin disease)
  2. Small for dates baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age)
  3. Substance abuse
  4. Vomiting
  5. Weight decreased
  6. Nipple disorder (disease of nipple)
  7. Complications of maternal exposure to therapeutic drugs
  8. Neonatal disorder (disease of neonates)
  9. Hydrocephalus (water on the brain)
  10. Nasal obstruction (blockage of nose)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Gait disturbance
  4. Mobility decreased (ability to move is reduced)
  5. Osteoporosis (bones weak and more likely to break)
  6. Renal failure (kidney dysfunction)
  7. Death
  8. Dysstasia (difficulty in standing)
  9. Foot fracture
  10. General physical health deterioration (weak health status)

What are the common drug interactions of Oxycontin and Viracept, by age (0-1 to 60+)? *:

0-1:

  1. Macrocephaly (a condition in which the head is larger than normal)
  2. Nasal obstruction (blockage of nose)
  3. Pregnancy
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Sepsis neonatal (a bacterial infection in the blood. it is found in infants during the first month of life)
  6. Nipple disorder (disease of nipple)
  7. Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues)
  8. Eye disorder
  9. Fever neonatal
  10. Hydrocephalus (water on the brain)

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug dependence
  2. Maternal exposure during pregnancy (use of substance during pregnancy)
  3. Substance abuse

30-39:

  1. Death
  2. Confusion
  3. Hallucination (an experience involving the perception of something not present)
  4. Overdose

40-49:

  1. Nipple disorder (disease of nipple)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Polysubstance abuse
  4. Renal failure acute (rapid kidney dysfunction)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Bone density decreased
  8. Chronic kidney disease
  9. Emotional distress
  10. Neonatal disorder (disease of neonates)

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Abdominal pain upper
  4. Alopecia (absence of hair from areas of the body)
  5. Antisocial behaviour
  6. Blood sodium decreased
  7. Chills (felling of cold)
  8. Dehydration (dryness resulting from the removal of water)
  9. Depression
  10. Dry skin

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Oxycontin and Viracept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Oxycontin and Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Oxycontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxycontin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viracept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on oxycodone hydrochloride and nelfinavir mesylate (the active ingredients of Oxycontin and Viracept, respectively), and Oxycontin and Viracept (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: